Drug intelligence / Profile preview

phenazopyridine + hyoscyamine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

This drug is a **combination** of phenazopyridine and hyoscyamine, typically used to relieve symptoms associated with irritation of the urinary tract, such as pain, burning, urgent or frequent urination, and bladder spasms. **Phenazopyridine** acts as a urinary tract analgesic, providing local pain relief to the lining of the urinary tract; it does not treat the underlying cause of infection but soothes discomfort[3][4][1]. **Hyoscyamine** is an anticholinergic/antispasmodic that inhibits muscarinic acetylcholine receptors, thereby reducing smooth muscle spasms in the bladder and urinary tract and decreasing symptoms like urgency and cramping[5][1]. This combination does not have unique branded formulations commonly in use, but related combinations with similar ingredients have existed (often also containing barbiturates).

02

Targets

mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on phenazopyridine + hyoscyamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phenazopyridine + hyoscyamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call